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1 These authors contributed equally to this project.Leukocytes play a central role in vein graft neointimal hyperplasia, which is signiﬁcantly augmented
under low shear conditions. The current concept is that shear force regulates leukocyte adhesion
predominately through up-regulation of chemokines and growth factors within the graft wall.
Using rabbit and murine vein graft models, we demonstrate that CC chemokine receptor 2/mono-
cyte chemoattractant protein-1 mediated monocyte recruitment and a low shear environment act
synergistically to augment neointimal hyperplasia development and removal of either of the condi-
tions leads to a signiﬁcant reduction in neointimal thickening. We propose a novel concept that the
shear stress response element phenotypically stems from the complex interplay of the biological
and physical microenvironments.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Although vein bypass grafting remains a mainstay for clinical
revascularization, accelerated neointimal hyperplasia develop-
ment leading to poor performance or complete luminal occlusion
occurs in up to 40% of grafts within one year of implantation [1].
While a variety of biologic processes have been implicated in path-
ologic vein graft remodeling, invasion of inﬂammatory cells has
increasingly been recognized as one of the dominant components
in these events [2,3]. CC chemokines, particularly monocyte che-
moattractant protein (MCP)-1 binding to CC chemokine receptor
2 (CCR2), appears to be central to the process of monocyte recruit-
ment and macrophage accumulation within developing lesions [4].
Beyond biologic factors, the local hemodynamic environment
stands among the important regulators of neointimal hyperplasia
development, where reductions in wall shear lead to substantial
augmentation in the rate of neointimal growth [5]. Grounded in
the pioneering work of Gimbrone and his identiﬁcation of positivelf of the Federation of European Bi
P-1, monocyte chemoattrac-
, Gainesville, FL 32610-0286,
eli).and negative shear stress response elements, the effect of altera-
tions in shear have been thought to induce local changes in chemo-
kine and growth factor transcription within the wall, leading to
differential growth of the neointima. In particular, leukocyte adhe-
sion has been demonstrated to be highly shear responsive second-
ary to the regulation of shear stress responsive element (SSRE)-
dependent, vascular adhesion molecules expressed on the endo-
thelial surface [6].
The current study attempts to deﬁne the relative importance
of leukocyte recruitment and wall shear in vein graft failure. Our
initial hypothesis was that modiﬁcation of MCP-1/CCR2-depen-
dent leukocyte recruitment would be the dominant regulator
of vein graft remodeling, with alterations in wall shear forces
providing a secondary, modulatory effect on the ﬁnal graft mor-
phology. Interestingly, the results suggest that there appears to
be substantial interplay between the physical and biologic sys-
tems for the complex process of neointimal hyperplasia. Speciﬁ-
cally, while reductions in ﬂow lead to enhanced leukocyte
accumulation and advanced neointimal hyperplasia, this is not
accomplished through an up-regulation of cell adhesion mole-
cules or augmentation of MCP-1/CCR2 signaling. These data sug-
gest that while increased chemokine expression may be
important in the early recruitment of leukocytes into the vein
graft wall, the differential accumulation of these cells is medi-
ated by the local effect of physical forces. Further investigationsochemical Societies.
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interaction between biologic mediators and physical forces,
where accelerated neointimal hyperplasia is observed only in
the presence of intact leukocyte recruitment pathways combined
with a favorable (low shear) hemodynamic environment for leu-
kocyte binding and transmigration.2. Materials and methods
2.1. Animal models of bypass vein grafting
This study conforms to the Guide for the Care and Use of Labo-
ratory Animals (NIH Publication No. 85-23). Male New Zealand
White rabbits underwent bilateral jugular vein interposition graft-
ing followed by immediate unilateral distal carotid artery branch
ligation to create two distinct ﬂow environments within the same
animal [5]. Vein grafts harvested at 1, 7 or 28 days postoperatively
were either snap frozen for biochemical analysis or perfusion ﬁxed
in situ (10% neutral buffered formalin) for immunohistochemical
and morphometric evaluation.
Murine vein grafts were created via interposition of an inferior
vena cava from a donor animal into the right common carotid ar-
tery of another animal. The right common carotid artery was di-
vided and each free end everted over a cuff and secured with a
10-0 suture. An inferior vena cava harvested from a separate ani-
mal was sleeved over the cuffed arterial ends and secured with an-
other 10-0 suture. Flow reduction was achieved through ligation of
the external carotid artery. Vein grafts were collected at 7 or 28
days postoperatively for detection of macrophages, biochemical
evaluation, or morphometric analysis.
2.2. MCP-1, CCR2, and E-selectin expression
The levels of MCP-1, CCR2, and E-selectin mRNA in rabbit and
murine vein grafts were measured using quantitative polymerase
chain reaction (RT-PCR) as detailed previously [7].
Murine vein grafts (harvested at 7 and 28 days) were stained
with monoclonal antibodies against MCP-1 and CCR2, using a dou-
ble label technique with confocal microscopy to identify speciﬁc
localization to endothelial or smooth muscle cells, as previously
described [8].
2.3. Leukocyte trafﬁcking to the vein graft wall
Early homing of circulating leukocytes to the vein graft wall
was evaluated with the bilateral rabbit vein graft model. Prior
to vein graft implantation, a total of 30ml of peripheral blood
was collected. Using a Percoll gradient (density: 1.096 and
1.076) centrifugation, total leukocytes were isolated and labeled
with CM-DiI per manufacturer’s instructions. Total leukocyte
recovery rates averaged 25%, with no difference in the proportion
of leukocyte subpopulations before and after cell processing. The
viability of the labeled leukocytes averaged 95% by trypan blue
measurements. The labeled cells (34 million cells) were then
delivered intravenously to the same animal immediately after
graft implantation. Twenty-four hours later, vein grafts were per-
fusion ﬁxed in situ, incised longitudinally, and mounted on glass
slides for immediate analysis. A two-photon confocal microscope,
with an effective depth of penetration of 500 lm, was used for
quantiﬁcation of CM-DiI positive cells throughout the entire
depth of the vein graft wall. Cell counts were normalized to the
concentration of positive cells in the blood and expressed as cells
per luminal surface area. Total number of cells counted per graft
averaged approximately 3100 and 1400 for low and high shear
grafts, respectively.2.4. Vein graft morphology and macrophage localization
Murine wild-type and CCR2/ vein grafts harvested at day 28
were used for morphologic evaluation. Two cross-sections from the
mid-portion of each graft underwent Masson staining for neointi-
mal area measurements, with the average used for statistical
analyses.
Murine wild-type and CCR2/ vein grafts were harvested at 7
days following exposure to high or low ﬂow. Histologic sections
(n = 10 per graft) were stained with an F4/80 speciﬁc antibody to
determine the macrophage content within the wall.2.5. Statistical analyses
Data are expressed as means ± standard error of the mean
(S.E.M.), and statistically meaningful differences determined using
two-way ANOVA or unpaired t-tests.3. Results
3.1. Flow regulation of MCP-1 and CCR2 expression
To assess the role of wall shear stress in modulating chemo-
kine and chemokine receptor transcription, rabbit vein grafts ex-
posed to reduced and elevated ﬂow rates were harvested 1, 7, and
28 days following implantation. In day 1 grafts, MCP-1 mRNA
content was signiﬁcantly up-regulated (P = 0.02), with an approx-
imate 20-fold increase above those levels present in vein seg-
ments pre-implantation (Fig. 1A). This early increase in MCP-1
declined to near baseline by day 28. Neither low nor high ﬂow
grafts demonstrated a difference in mRNA expression patterns
in response to the differential ﬂow conditions (P = NS, low vs.
high ﬂow).
CCR2 transcription was also signiﬁcantly enhanced in day 1 rab-
bit vein grafts (P < 0.001, Fig. 1B), but in contrast to MCP-1, the
augmentation of CCR2 remained elevated 28 days following
implantation (P < 0.001). Similar to MCP-1, no notable difference
in CCR2 mRNA content was observed between low and high ﬂow
grafts. Comparable ﬂow-independent elevations in MCP-1 and
CCR2 transcription were conﬁrmed in murine vein grafts 7 days
after implantation (Fig. 1A and B).
The distributions of MCP-1 and CCR2 within the murine vein
graft are shown in Fig. 2. Although highest near the luminal sur-
face, broad expression of both of MCP-1 and CCR2 are noted
throughout the wall.3.2. Effect of wall shear on leukocyte binding and transmigration
With an evolving understanding of the role of cell mediated
inﬂammation in the progression of neointimal hyperplasia, the
binding and transmigration of leukocytes into low and high ﬂow
rabbit vein grafts was investigated. Following the CM-DiI labeling
of leukocytes at the time of graft implantation, day 1 vein grafts
were assayed using two-photon confocal microscopy (Fig. 3A).
Vein grafts subjected to low blood ﬂow rates demonstrated a 2-fold
increase in the density of surface adherent or transmigrated leuko-
cytes, compared to high ﬂow grafts (Fig. 3B).
To examine the potential role of endothelial surface adhesion
molecules as the underlying mechanism for the difference in leu-
kocyte recruitment, E-selectin gene expression in high and low
ﬂow rabbit vein grafts was assayed (Fig. 3C). Although a clear
time-dependent effect was evident, with an early up-regulation
of E-selectin (P < 0.001), no differences in E-selectin expression
were observed between high and low ﬂow grafts.
Fig. 1. mRNA expression of MCP-1 (A) and CCR2 (B). Signiﬁcant up-regulation of
MCP-1 (P < 0.001) and CCR2 (P < 0.001) was observed in rabbit vein grafts following
implantation. Rabbit MCP-1 demonstrated a return towards baseline (P = 0.003) but
CCR2 remained elevated (P = NS) throughout the 28 days. No difference in rabbit
MCP-1 or CCR2 mRNA content was observed between low and high ﬂow grafts.
(n = 4–9 per group) Signiﬁcant increases in MCP-1 (P = 0.004) and CCR2 murine, 7-
day vein grafts were also observed, with this increase independent of the imposed
ﬂow (n = 4 per group).
Fig. 2. Distribution of MCP-1 and CCR2 in murine vein grafts 28 days following impl
endothelial and smooth muscle cells, respectively, demonstrate a broad distribution of
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To directly assess the interaction between CCR2-mediated mac-
rophage recruitment and wall shear stress, a mouse vein graft
model was utilized. CCR/ and wild-type murine vein grafts ex-
posed to reduced and elevated blood ﬂow rates were harvested at 7
and 28 days following implantation. Consistent with the rabbit
grafts, neointimal hyperplasia in 28 day wild-type murine vein
grafts was augmented under low ﬂow conditions (P = 0.04,
Fig. 4). In contrast, vein grafts lacking CCR2 demonstrated no dif-
ference in neointimal area under low and high ﬂow conditions,
with the magnitude of neointimal thickening in both high and
low ﬂow CCR/ grafts similar to high ﬂow, wild-type controls
(P = NS). Examination of F4/80 staining in day 7 vein grafts sup-
ported the importance of the MCP-1/CCR2 axis in macrophage
recruitment under low ﬂow conditions, as evidenced by a 39%
and 44% reduction in macrophage content in high ﬂow, wild-type
and low ﬂow, CCR2/ grafts, compared to low ﬂow, wild-type
controls (Fig. 5). These data demonstrate that both a favorable
(low shear) hemodynamic condition and intact macrophage che-
motactic pathways are required for the recruitment of macro-
phages and the accelerated development of neointimal
hyperplasia. The absence of either of these conditions leads to a
notable reduction in neointimal thickening.
4. Discussion
Vein grafts adapt to the arterial environment by neointimal
thickening. Medial smooth muscle cells undergo a conversion from
a contractile to synthetic phenotype and migrate to the neointimal
layer where these cells proliferate and lay down extracellular ma-
trix proteins. Vital to understanding these events, however, is the
clinical observation that vein graft occlusive disease is segmental,
with clear regional variability in the processes that drive the wall
towards an adaptive or pathologic phenotype [9,10]. Local wall
shearing forces have been postulated as a major regulator of these
events where reductions in wall shear have been demonstrated to
be critical components leading to accelerated neointimal hyperpla-
sia and vein graft failure.antation. Von Willebrand Factor (vWF) and a-actin staining, for identiﬁcation of
MCP-1 and CCR throughout the wall without cell-speciﬁc localization.
Fig. 3. Shear regulated leukocyte recruitment and inﬁltration in rabbit vein grafts. Two-photon confocal laser scan images demonstrating CM-DiI labeled leukocytes
transmigrated into the graft wall 24-h after graft implantation (A). Quantitatively, leukocyte binding and transmigration was increased 2-fold in low ﬂow versus high ﬂow
vein grafts (B) (n = 4 per group). This ﬂow-dependent difference in leukocyte binding was independent of E-selectin mRNA expression (C) (n = 4–5 per group).
Fig. 4. Flow regulated neointimal hyperplasia in CCR2/ and wild-type vein grafts. While reduction in ﬂow accelerated neointimal hyperplasia in wild-type vein grafts
(P = 0.04), this augmentation was abolished when CCR2 was absent. Absence of the CCR2 receptor had an inﬂuence only under low ﬂow conditions, where signiﬁcant
attenuation in neointimal hyperplasia was observed with loss of this signaling pathway (P = 0.01) (n = 8 per group).
Fig. 5. F4/80 antibody staining of day 7, murine vein grafts (10 sections per graft). Low ﬂow, wild-type grafts demonstrated a notable increase in macrophage content
compared to high ﬂow, wild-type grafts or low ﬂow grafts lacking the CCR2 receptor (n = 3 per group).
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function comes primarily from in vitro studies, where it has beendemonstrated that genes important to vascular endothelial physi-
ology are all inﬂuenced by this stimulus [11,12] Several candidate
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which include integrins, ion channels, G proteins, and MAPK cou-
pled receptors. Acting through a shear stress responsive element,
consisting of a 6-bp core element (GAGACC) in many promoter re-
gions, NF-jB, AP-1, Sp-1, and Erg-1 can be activated by changes in
shear [13]. Despite these signiﬁcant insights into the interaction of
the endothelium with the ﬂow environment, in vivo evidence of
their biologic signiﬁcance is limited.
Several strong lines of evidence suggest an important role for
monocytes in the development of neointimal hyperplasia follow-
ing vascular injury [14,15]. Among the seminal works in this area
was completed by Richter et al. [16], who demonstrated monocyte
transmigration to be enhanced in regions of low shear following
stent placement within an arterial bifurcation. Subsequent histo-
logic analysis conﬁrmed these areas to be the sites with advanced
neointimal thickening. To further validate this critical link between
the circulating inﬂammatory cell and the physical microenviron-
ment in vein graft adaptation, we utilized a transgenic mouse lack-
ing the CCR2 chemokine receptor, a vital link in the homing of
leukocytes to sites of vascular injury. Using a partial distal ligation
approach in this murine model, low shear CCR2/ vein grafts
demonstrated signiﬁcantly less neointimal thickening than low
shear controls, yet CCR2/ neointimal thickening was not differ-
ent from wild-type controls in the high shear setting (Fig. 3). These
data support the conclusion that CCR2/MCP-1 monocyte recruit-
ment and a low shear environment act synergistically to augment
neointimal hyperplasia development and removal of either of the
conditions leads to a signiﬁcant reduction in neointimal thicken-
ing. Taken together, these experiments indicate a critical interac-
tion between local hemodynamics and monocyte recruitment,
and suggest a novel concept for the ‘‘shear stress response ele-
ment”. Rather than a response based largely on biologic perturba-
tions induced by shear (e.g. changes in gene expression), we
theorize that the SSRE phenotypically stems from the complex
interplay between the biologic and physical microenvironments
that modulate the process of vascular adaptation.
In summary, the interaction between shear force and biologic
mediators suggest that the impact of shear stress on neointimal
hyperplasia is more complex than can be described through the
expression and production of a limited set of key cytokines or sig-
naling mediators. We theorize that the physical and biologic envi-
ronments are implicitly linked and lead to speciﬁc vein graft
phenotypes. Fundamental to this study is the concept that leuko-
cyte entry into the wall is shear-dependent and that once entering
the wall, these activated inﬂammatory cells have a critical role in
vascular adaptation. Focusing on the critical process of monocyte
entry into wall, we have identiﬁed that both chemokine up-regula-
tion and reduced shear (with increased leukocyte binding and en-
try into the wall) are necessary to drive the neointimal
hyperplastic response.Acknowledgements
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